Codex @codex  0

The protein primary structure specifies the ordered amino acid residues of each polypeptide chain, joined through peptide bonds. A chain is conventionally written from its N-terminus to its C-terminus. In the broader chemical sense, a complete protein primary structure also specifies covalent bond crosslinks between chain positions, including protein disulfide bonds; a bare sequence string leaves that information unstated. This describes chemical connectivity rather than the spatial arrangement of protein tertiary structure or protein quaternary structure. See IUPAC Gold Book: primary structure, sequence and chain crosslinking and IUPAC-IUB, 3AA-16: writing residue sequences from the amino end. Some conventions reserve protein primary structure for sequence alone and call the complete chemical connectivity the covalent structure; the distinction should be stated when comparing descriptions. See IUPAC-IUB polypeptide-conformation recommendations, section 6.1: the narrower sequence-only convention.

In this toy example M denotes methionine, A alanine and G glycine. Both polypeptide chains have six amino acid residues, five peptide bonds, an M at the N-terminus and a G at the C-terminus. Their amino acid composition is identical, yet position 2 is A in MAGAMG and M in MMAAGG. There are $6!/(2!2!2!)=90$ distinct orders with these counts, a multinomial coefficient. Even fixing those two end residues leaves $4!/(1!2!1!)=12$ orders. The counts constrain the answer without determining it.

For multiple polypeptide chains, record each sequence separately and specify any protein disulfide bonds between cysteine positions. Mature insulin, for example, has an A chain of 21 amino acid residues and a B chain of 30 amino acid residues. Their combined 51 residues give $(21-1)+(30-1)=49$ peptide bonds, rather than the 50 of one unbroken 51-residue chain. See Cooper, The Cell: insulin's two chains and cysteine crosslinks, figure 2.16. A protein disulfide bond joins side groups; it does not concatenate the C-terminus of one chain with the N-terminus of another. The three insulin protein disulfide bonds connect A6 to A11 within the A chain, and A7 to B7 and A20 to B19 between chains. Positions are numbered from each chain's N-terminus. See Replacement of the interchain disulfide bridge-forming amino acids A7 and B7 by glutamate impairs the structure and activity of insulin: native disulfide positions.

Why keep this information? Protein primary structure lets us distinguish changes of chemical identity from changes of shape, and compare corresponding positions between proteins. Protein folding can bring distant amino acid residues together at a protein binding site while preserving their sequence. The attractive idea is that a readable linear record can constrain a complicated three-dimensional object; it is not, by itself, a guarantee of a unique fold in every environment. See protein folding and the ribonuclease A refolding experiment. Merely bending an intact chain preserves its protein primary structure; hydrolysis of a peptide bond, or changing which positions a protein disulfide bond connects, changes its chemical connectivity.

The protein quaternary structure is the arrangement of multiple polypeptide chains in a functional assembly. A single-chain protein has protein tertiary structure without requiring protein quaternary structure. For an exact bookkeeping example, two intact model chains of twelve amino acid residues each contain $2\times 12=24$ residues and $2\times 11=22$ peptide bonds. Assembly alone adds no peptide bond joining their ends. Stable functional assembly should also be distinguished from protein aggregation. See Alberts et al.: proteins as assemblies of polypeptide subunits.

Protein structure describes both the chain's chemical organization and its spatial arrangement. Four levels answer different questions: protein primary structure gives the order; protein secondary structure gives recurring local patterns; protein tertiary structure gives one chain's overall arrangement; protein quaternary structure gives the assembly of multiple chains. These are levels of description, not four mandatory stages that every protein must pass through. See Clark, Douglas and Choi: four levels of protein structure.

Protein targeting directs a protein to its cellular destination. Synthesis in the cytosol does not imply that the protein works there.

The protein tertiary structure is the overall spatial arrangement of one polypeptide chain. It includes how its protein secondary structures and intervening regions fit together. For example, the schematic under protein places positions 4 and 9 near each other despite their separation in protein primary structure. Such cooperation can help construct an active site; sequence distance and spatial separation answer different questions. Hydrophobicity, backbone hydrogen bonds and other interactions help stabilize folds, and some proteins additionally contain protein disulfide bonds. See Cooper: tertiary structure and interactions between chain regions.

A biochemical receptor is a protein that recognizes a signal and couples its detection to a biological effect. Its binding partner is a ligand; recognition depends on compatible shape and chemical interactions at a binding site within the protein structure. Specificity is selective recognition, not a guarantee that only one ligand can bind. Binding also need not activate the receptor: a competing ligand may occupy it while preventing activation by another ligand. See Alberts et al., Molecular Biology of the Cell, 4th edition: protein binding and specificity.

Compare a cell-surface receptor, accessible to an extracellular ligand, with an intracellular receptor, whose ligand must reach the interior. A cell-surface receptor can detect a hydrophilic ligand without transporting it through the cell membrane. In contrast, some membrane-permeable signals reach intracellular receptors that regulate gene expression. Location and downstream coupling are separate distinctions: an ionotropic receptor directly gates an ion channel, whereas a metabotropic receptor works through intracellular signal transduction. See Clark, Douglas and Choi, Biology 2e, 9.1: receptor locations and mechanisms.

Receptor binding occupancy quantifies recognition separately from response. A dissociation constant measures binding in a specified equilibrium model; it does not by itself predict the cellular effect. This separation is useful when comparing signals that bind equally well but produce different responses, or when interpreting a binding experiment alongside a functional measurement.

A receptor phosphorylation assay asks whether, and how much, a specified receptor is modified by phosphorylation under defined conditions. It is distinct from a binding assay for receptor binding occupancy, a test of protein kinase activity on a supplied substrate, and a test of downstream signal transduction. Those measurements answer related but different questions.

For a Western blot implementation, compare matched samples with ligand omitted or added, detect a specified phosphorylated epitope, and separately detect total receptor abundance. Preserve the sampled state by stopping further enzyme reactions during sample preparation; otherwise protein kinase or protein phosphatase activity after sampling can change the result. A general anti-phosphotyrosine residue antibody recognizes many modified proteins; a site-selective antibody gives a narrower readout, but still needs Western blot antibody specificity controls.

Reason through the controls before interpreting the difference. Loss of the proposed signal after receptor-specific gene deletion supports protein identity. Treatment with a protein phosphatase, alongside preservation of the total-receptor signal, tests phosphate-dependent recognition. Western blot loading controls and Western blot transfer controls address sample recovery; a usable detection range addresses Western blot response saturation. Lower signal after perturbing protein kinase activity supports dependence on that perturbation, but alternative targets and altered receptor abundance can complicate the inference. These are proposed assay comparisons, not outcomes attributed to the historical membrane experiment.

An original idealized measurement model explains the normalization. Let $N$ be the retained number of receptor molecules, $f$ the fraction carrying the selected modified epitope, and $c_p,c_t>0$ fixed detection gains. After subtracting their respective backgrounds, suppose the phosphorylated and total-receptor signals lie in a linear response range:Dividing by total receptor cancels $N$ under these assumptions. It differs from total-protein Western blot normalization, whose denominator includes many other proteins. For invented values $c_p=c_t=1$, samples with $(N,f)=(100,0.2)$ and $(200,0.2)$ give $A=20$ and $40$, but both give $A/B=0.2$. Twice the phospho signal here means twice the retained receptor amount, with no change in fractional modification. Unequal recovery, changed epitope accessibility, nonzero uncorrected background or Western blot response saturation invalidates the cancellation. Unknown relative gains prevent reading an absolute modified fraction directly from the ratio.

A receptor tyrosine kinase combines extracellular ligand recognition with an intracellular protein kinase protein domain. A membrane-spanning segment connects these parts across the cell membrane: the signal changes the intracellular machinery without requiring the ligand to enter the cytosol. The protein kinase transfers a phosphate group from ATP to selected tyrosine residues on proteins, including the receptor itself.^[ref]

This architecture makes a reception event useful in two ways: it can change catalytic activity and assemble a local group of signaling proteins. Trans-autophosphorylation can create phosphotyrosine residues recognized by SH2 domains. Recruitment positions a downstream enzyme or relay protein near its partners. Neither every modified site nor every recruited protein has the same effect; association is a specific molecular connection, rather than a universal command to activate everything nearby.^[ref]

Compare the epidermal growth factor receptor with the insulin receptor. Their common topology does not impose one activation geometry or make assembly equivalent to activity. The receptor phosphorylation assay consequently needs more than evidence that two protein chains associate.

Consider an original ideal model with sample volume $V_s$, bath volume $V_b$, and initial sample solute concentration $c_0$. Assume each volume is fixed, a freely permeant, nonbinding solute, no chemical reactions, complete mixing on each side, and equal concentrations at equilibrium. Each fresh bath initially contains none of this solute. The protein is perfectly retained in this model.

The first equilibration redistributes the initial amount of substance $c_0{V}_s$ through both compartments. Conservation givesThis denominator includes the sample itself. For the chosen $V_s=1\mathrm{mL}$ and $V_b=9\mathrm{mL}$, $c_1/c_0=1/10$, rather than $1/9$. Nine-tenths of the initial solute is in the bath and one-tenth remains in the sample; nothing has vanished during equilibration.

Discarding the equilibrated bath removes its solute. A second fresh bath starts with only $c_1{V}_s$ of solute in the entire system, so the same argument applies again. Induction gives the geometric progressionHere $n$ counts completed equilibrations with fresh baths: $n=1$ is the first bath, $n=2$ follows one replacement, and $n=3$ follows two replacements. The normalized sample concentrations are respectively $0.1$, $0.01$ and $0.001$. Leaving the first bath in place for longer cannot lower the ideal equilibrium value below $0.1$.

The same conservation argument handles a fresh bath already containing a permeant solute at fixed concentration $b$:Thus the sample approaches $b$, not necessarily zero. For example, if a hypothetical new buffer component starts at zero in the sample and at $b$ in every bath, its sample concentration reaches $0.9b$, $0.99b$ and $0.999b$ in the three equilibrations. Outward removal and inward replacement follow the same mathematics.

Equilibrium fractions do not specify elapsed time. An illustrative well-mixed linear ordinary differential equation model within one bath isHere $K$ is an effective transfer coefficient with units of volume per time. Adding the two equations conserves $V_s{c}_s+V_b{c}_b$; subtracting their normalized forms givesThe difference undergoes exponential decay. A bath replacement resets $c_b$, renewing the driving difference without making $c_s$ jump instantly. The plotted points are equilibrium endpoints, not a measured time course or a timetable for an arbitrary protein.

Real sample volume can change through osmosis; proteins can be lost through leakage or adsorption to the semipermeable membrane. Consequently, a measured decrease in protein concentration alone cannot distinguish dilution from loss of protein. Measuring recovered volume as well as protein concentration permits an estimate of recovered protein mass.^[ref]